Skip to content

APOL

Apollon Formularies plc

Access


ISIN

IM00BJ0LRD77

Bid

0.12

Mid

0.16

Ask

0.20

Key Information

Price Change
0.00%
Year High
1.65
Year Low
0.16
Last Trade
2 Jun 23
Market Cap
£1.23M
Par
0.00
Bid
0.12
Mid Price
0.16
Ask
0.20
Instrument Type
Ordinary Shares
MIFID Status
MTF
Tradable Securities
771.2M
Sector
Healthcare

Prices in GBX except for Market Cap in GBP

About Apollon Formularies plc

Apollon Formularies Plc is a medical cannabis company based in the Commonwealth of Jamaica. It holds a suite of licences that allow for fully regulated seed through to human trial & drug discovery designed for patient treatment applications. Apollon Jamaica (Apollon UK’s subsidiary) is Cannabis Licensing Authority approved to produce large scale full spectrum cannabis oils that it can sell to patients via its regulated dispensary located at its state-of-the-art large scale processing laboratory, Negril, Jamaica. Apollon Jamaica is fitted to produce high volume, high quality, full spectrum medical cannabis oil with both high and low THC content and holds a Research & Development full spectrum license (inclusive of THC). This allows the company to undertake physician-led, medically supervised treatments for the purposes of drug discovery, all overseen and approved by the Jamaican Ministry of Health. The company’s aim is to ensure that Apollon is the recognised global brand for quality, consistency and efficacy.

Apollon Formularies plcAccess

Latest Trades

DateVolumePrice (GBX)Value (GBP)

02 Jun 23

11:48

500,0000.14700.00

30 May 23

15:40

21,512,5540.1838,722.60

30 May 23

15:40

6,233,8660.1710,597.57

30 May 23

15:39

15,278,6880.1725,973.77

25 May 23

11:20

500,0000.17850.00
View all trades

Latest Announcements

DateTitle

10 May 23

17:05

Apollon Formularies Plc - Update on Global Hemp Group

11 Apr 23

14:00

Apollon Formularies Plc - Result of General Meeting

21 Mar 23

12:00

Apollon Formularies Plc - 28 day due diligence extension for Asset sale

15 Mar 23

07:00

Apollon Formularies - Notice of General Meeting

12 Jan 23

07:00

Apollon Formularies - Execution of Binding Letter of Intent with GHG
View all announcements

Address

Registered Address

42 One Love Drive, West End, Negril, Westmoreland, Jamaica

Email

barnhillmd@sprynet.com

Phone

+44 (0)20 7440 0640

Contacts

Corporate Adviser

Peterhouse Capital Ltd, 3rd Floor, 80 Cheapside, London, EC2V 6EE, United Kingdom

Registrar

Share Registrars Ltd, 3 The Millennium Centre, Crosby Way, Farnham, Surrey, GU9 7XX, United Kingdom
Loading...

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2023. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal